November 1, 2007 -- Greatbatch has signed a definitive asset purchase agreement to acquire Quan Emerteq for approximately $55 million in cash. The company said it expects to close this transaction in November.
Quan Emerteq, based in Blaine, Minn., designs, develops and manufactures single-use medical devices for the vascular, cardiac rhythm management and neurostimulation markets.
Greatbatch anticipates that Quan Emerteq will have annual sales in the range of $20 million to $24 million for 2007.
Source: FDAnews Device Daily Bulletin
